Lichen sclerosus et atrophicus responding to methotrexate

Clinical and Experimental Dermatology

Volumn 33, Issue 5, 2008, Pages 651-652

  Nayeemuddin, F ^a   Yates, V M ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CLOBETASOL PROPIONATE; METHOTREXATE; TACROLIMUS;

ADULT; BLISTER; CASE REPORT; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LETTER; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; SKIN ATROPHY; SKIN BIOPSY; SKIN TIGHTNESS; THYROID FUNCTION; TREATMENT FAILURE; TREATMENT RESPONSE;

DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 49649084728     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02721.x     Document Type: Letter

References (5)

1. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphoea. J Am Acad Dermatol 1998 39: 220 5.
2. Klein LE, Cohen SR, Weinstein M. Bullous lichen sclerosus et atrophicus: treatment by tangential excision. J Am Acad Dermatol 1984 10: 346 50.
3. Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997 136: 356 9.
4. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002 46: 251 5.
5. Harrington CI, Dunsmore IR. An investigation into the incidence of autoimmune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981 104: 563 6.